AT
Alterity Therapeutics Ltd
🇺🇸XNAS.ATHEUnited StatesHealthcare
$3.68USDdown -0.18 (-4.66%)OpenEnd of day3:16 PM
Price$3.68-0.18 (-4.66%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US02155X2053
- CUSIP
- 02155X106
Company
- Employees
- 11
- Headquarters
- Melbourne, United States
- CEO
- Dr. David A. Stamler M.D.
Market
- Shares outstanding
- 18.2M
- Market cap
- $67.01M
Highlights
- Market cap
- $67.01M
- EPS LTM
- -A$0.97
- P/E LTM
- -6.38
- Div yield
- 0%
Fundamentals (LTM)
- Revenue
- A$6.24M+3.53%up year on year
- Net income
- -A$12.15M+57.65%up year on year
- Gross margin
- 97.45%+1.75%up year on year
- Free cash flow
- -A$22.52M-44.19%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.